Autolus Therapeutics

NASDAQ: AUTL · Real-Time Price · USD
1.73
-0.12 (-6.49%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:55 PM EDT

Autolus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
227.38M 239.57M 382.44M 310.34M
Short-Term Investments
360.64M n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.13M 1.36M 4.01M 4.4M
Receivables
48.24M 1.05M 153K 68K
Inventory
4.14M n/a 14.16M 10.12M
Other Current Assets
5.32M 26.05M 30.84M 27.83M
Total Current Assets
660.93M 275.3M 425.77M 346.95M
Property-Plant & Equipment
105.05M 95.65M 58.42M 52.32M
Goodwill & Intangibles
12.37M n/a n/a 65K
Total Long-Term Assets
121.8M 100.08M 64.5M 58.61M
Total Assets
782.73M 375.38M 490.27M 405.56M
Account Payables
1.97M 103K 531K 431K
Deferred Revenue
n/a n/a n/a 23.52M
Short-Term Debt
n/a n/a 5.04M n/a
Other Current Liabilities
58.77M 15.29M 25.58M 14.92M
Total Current Liabilities
60.74M 44.74M 46.37M 28.55M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
245.03M 171.26M 126.02M 47.14M
Total Long-Term Liabilities
294.66M 219.17M 145.23M 63.69M
Total Liabilities
355.4M 263.91M 191.6M 92.24M
Total Debt
52.63M 52.97M 24.26M 21M
Common Stock
12K 8K 8K 4K
Retained Earnings
-1.1B -878.56M -670.18M -521.34M
Comprehensive Income
-29.17M -28.99M -38.9M -8.57M
Shareholders Equity
427.32M 111.47M 298.67M 313.32M
Total Investments
360.64M n/a n/a n/a